Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Johnson

Showing results (241-250 of 262) with videos related to

Pageof 27
Sort By:
Gastroenterology|December 26, 2012
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese populationKeiko Yamazaki, Junji Umeno, Atsushi Takahashi, et al.
BMJ Open|November 18, 2017
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitusMichael Alan Glaysher, Aruchuna Mohanaruban, Christina Gabriele Prechtl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK InhibitionRebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, et al.
European Journal of Human Genetics : EJHG|April 30, 2015
Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP arraySantiago Rodriguez, Tom R Gaunt, Yiran Guo, et al.
Environmental Science & Technology|March 28, 2026
Diving into AI? Exploring the Potential for AI to Tackle Complex Water Quality ChallengesEdoardo Borgomeo, Luke A Holmes, Camilla G Billari, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|March 6, 2024
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet componentsAllison P Wheeler, Edward L Snyder, Majed Refaai, et al.
Blood|January 29, 2021
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimationLouisa Goumidi, Florian Thibord, Kerri L Wiggins, et al.
Transfusion|June 24, 2022
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet componentsEdward L Snyder, Allison P Wheeler, Majed Refaai, et al.
Pageof 27

Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Gastroenterology|December 26, 2012
A genome-wide association study identifies 2 susceptibility Loci for Crohn's disease in a Japanese populationKeiko Yamazaki, Junji Umeno, Atsushi Takahashi, et al.
BMJ Open|November 18, 2017
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitusMichael Alan Glaysher, Aruchuna Mohanaruban, Christina Gabriele Prechtl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2020
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK InhibitionRebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, et al.
European Journal of Human Genetics : EJHG|April 30, 2015
Lipids, obesity and gallbladder disease in women: insights from genetic studies using the cardiovascular gene-centric 50K SNP arraySantiago Rodriguez, Tom R Gaunt, Yiran Guo, et al.
Environmental Science & Technology|March 28, 2026
Diving into AI? Exploring the Potential for AI to Tackle Complex Water Quality ChallengesEdoardo Borgomeo, Luke A Holmes, Camilla G Billari, et al.
BMJ Open|July 21, 2022
Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trialZahra N Sohani, Guillaume Butler-Laporte, Andrew Aw, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|March 6, 2024
Acute pulmonary injury in hematology patients supported with pathogen-reduced and conventional platelet componentsAllison P Wheeler, Edward L Snyder, Majed Refaai, et al.
Blood|January 29, 2021
Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimationLouisa Goumidi, Florian Thibord, Kerri L Wiggins, et al.
Transfusion|June 24, 2022
Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet componentsEdward L Snyder, Allison P Wheeler, Majed Refaai, et al.
Pageof 27